期刊文献+

高敏C反应蛋白水平与肥胖及糖代谢异常儿童相关因素的研究 被引量:7

Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents
原文传递
导出
摘要 目的 了解高敏C反应蛋白(hs-CRP)与肥胖及糖代谢异常儿童的体量指标及血清参数相关性;探讨hs-CRP与儿童肥胖患者及糖尿病或糖代谢异常的关系。方法 选择肥胖儿童70例作为研究对象,并选择正常儿童30例作为对照组(组1),根据OGTF试验将肥胖儿童分为不伴糖代谢异常组54例(组2)和糖代谢异常组16例(组3),测定体量指标及相关参数。结果 肥胖儿童hs-CRP水平2.44(0.01~14.6)mg/L,明显高于对照组[0.1(0.01-2.1)mg/L]。血糖和血脂于正常范围时,肥胖儿童的hs-CRP水平为2.4(0.01-9.0)mg/L,胰岛素抵抗指数(IRI)明显升高。糖脂代谢异常时,hs-CRP水平为2.6(0.1-14.6)mg/L。Pearson相关分析显示,血清hs-CRP水平与BMI、腰围、臀围、腰臀比呈正相关,其中与BMI的相关性最强,多元线性回归分析示,BMI是惟一与hs-CRP相关的指标。结论 肥胖儿童存在低度炎症状态和胰岛素抵抗。hs-CRP与BMI独立相关。hs-CRP和胰岛素抵抗指数的异常升高早于血糖和血脂,hs-CRP增高对糖脂代谢的异常有较好的预测能力。 Objective High-sensitivity C-reactive protein (hs-CRP) may predict the development of type 2 diabetes mellitus ( T2DM ), metabolic syndrome (MS) and cardiovascular diseases ( CVD ) in adult, but few reports on relevant studies in children are available. The present study aimed to understand possible correlation between serum hs-CRP levels and some factors of obese children and adolescents with or without impaired glycometabolism. Methods Seventy obese children and adolescents (age 8-17 years) and 30 non-obese healthy controls (group 1,20 boys and 10 girls, mean age 12. 6 years) were enrolled into this study. The obese individuals were subdivided into two groups according to the results of oral glucose tolerance test: the obese subjects without IGR ( group 2, 54 cases, 43 boys and 11 girls, mean age 11.3 years) and the obese subjects with impaired glycometabolism (group 3, 16 cases, 8 boys and 8 girls, mean age 12.8 years). The levels of serum parameters including hs-CRP, glucose, lipid, insulin, C-peptide and whole blood HbAlc were determined. SPSS 10.0 was used for statistical analysis. Results (1)There was significant increase of serum hs-CRP level in obese children and adolescents, the median was 2.44(0.01 ~ 14.6) rag/L; the level of control group was 0. 1 ( 0. 01 - 2. 1 ) mg/L ( 2 ) Some of the following parameters, such as fasting plasma glucose (FPG), triglyceride (TG), fasting insulin (FINS), C-peptide (Cp) and insulin resistance index (IRI), were found increased in group 2 and 3 as compared to group 1. When FPG and TG were still in normal range in group 2, the levels of hs-CRP and IRI were significantly higher than those in group 1, the level of hs-CRP was 2.4(0.01 -9.0) mg/L. While FPG and TG were abnormal in group 3, the level of hs-CRP was 2. 6(0. 1 - 14. 6) mg/L, but the difference had no statistical significance. (3) Pearson correlation analysis showed that there was a moderate correlation between serum hs-CRP and BMI ( r = 0. 414, P = 0. 000 ) . There was a low correlation between hs-CRP and waist circumference, hip circumference and waist to hip ratio (WHR). The correlation of serum hs-CRP with blood pressure, TG, cholesterol, high density lipoprotein-eholesterol (HDL-C), HbAle, FPG, FINS and Cp had no significant deviation. (4) Multiple linear regression analysis showed that body mass index (BMI) was the only indicator which had correlation with hs-CRP. Conclusion ( 1 ) There may be a chronic low-grade inflammation and insulin resistance in obese children. (2) The level of hs-CRP might be independently correlated with BMI in children. ( 3 ) Hs-CRP and IRI elevated before FPG and TG did, which may suggest that the low-grade inflammation and insulin resistance may be a pathogenic base of DM rather than the outcome of it. (4) The elevation of hs-CRP may help predict impaired glucose and lipid metabolism.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2006年第12期933-936,共4页 Chinese Journal of Pediatrics
基金 首都医学发展科研基金(2002-2005)
关键词 C反应蛋白质 肥胖症 儿童 葡萄糖代谢障碍 C-reactive protein Obesity Children Glucose metabolism disorders
  • 相关文献

参考文献8

  • 1中国肥胖问题工作组,季成叶.中国学龄儿童青少年超重、肥胖筛查体重指数值分类标准[J].中华流行病学杂志,2004,25(2):97-102. 被引量:2025
  • 2Pickup JC,Crook MA.Is type Ⅱ diabetes mellitus a disease of the innate immune system? Diabetologia,1998,41:1241-1248
  • 3Ford ES.Body mass index,diabetes,and C-reactive protein among U.S.adults.Diabetes Care,1999,2:1971-1977.
  • 4Visser M,Bouter LM,McQuillan GM,et al.Low-grade systemic inflammation in overweight children.Pediatrics,2001,107:E13-E18.
  • 5Ford ES,Galuska DA,Gillespie C,et al.C-reactive protein and body mass index in children:findings from the Third National Health and Nutrition Examination Survey,1988-1994.J Pediatr,2001,138:486-492.
  • 6Lambert M,Delvin EE,Paradis G,et al.C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents.Clin Chem,2004,50:1762-1768.
  • 7Ford ES.C-Reactive protein concentration and cardiovascular disease risk factors in children:findings from the National Health and Nutrition Examination Survey 1999-2000.Circulation,2003,108:1053-1058.
  • 8Ridker PM,Wilson PW,Grundy SM.Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation,2004,109:2818-2825.

二级参考文献14

  • 1Bellizzi MC, Dietz WH. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr,1999,70∶s173-s175.
  • 2Zhou BF. Predictive values of body mass index and waist circumfer-ence for risk factors of certain related disease in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomedical and Environ ment
  • 3Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ, 2000, 320∶1240-1243.
  • 4Malina RM, Katzmarzyk PT. Validity of the body mass index as an indicator of the risk and presencr of overweight in adolescents. Am J Clin Nutr,1999,70∶131-136.
  • 5Flegal KM, Carrol MD, Kuczmarski RJ, et al.Overweight and obesity in the United States: Prevalence and trends.Int J Obes,1998,22∶39-47.
  • 6He Q, Albertsson-Wikland K,Karlberg J.Population-based body mass index reference values from Goteborg Sweden: birth to 18 years of age. Acta Paediatr,2000,89∶582-592.
  • 7Deniels SR, Khoury PR, Morrison JA.The utility of body mass index as a measure of body fatness in childhood and adolescents: differences by race and gender.Pediatrics,1997,99∶804-807.
  • 8WHO. Obesity: preventing and managing. The global epidemic. Report of a WHO consultation on obesity. Technical Report Series,Geneva,WHO,2000,894∶83.
  • 9日本肥满学会肥满症诊断基准检讨委员会.肥满筛查和肥满症诊断新基准[J].(日)肥满研究,2000,6:18-28.
  • 10丁宗一,杜丽蓉.167065名中国0~7岁儿童BMI/Kaup指数研究[J].中华儿科杂志,2002,40(4):222-224. 被引量:53

共引文献2021

同被引文献90

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部